Evolus Inc.
EOLS | NASDAQ
$8.20
+$0.21 (+2.63%)
Sep 22, 2026, 1:51 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | 297.18M | 266.27M | 202.09M | 148.62M | 99.67M | 56.54M |
Cost of Revenue | 104.41M | 83.97M | 61.56M | 58.84M | 43.53M | 18.3M |
Gross Profit | 192.76M | 182.3M | 140.53M | 89.77M | 56.14M | 38.24M |
Operating Income | -37.6M | -34.41M | -49.23M | -65.33M | -44.41M | -153.07M |
Interest Income | 1.93M | 3.26M | 860K | 119K | 1K | 635K |
Pretax Income | -50.96M | -49.76M | -61.51M | -74.32M | -46.77M | -162.94M |
Net Income | -51.64M | -50.42M | -61.69M | -74.41M | -46.81M | -163.01M |
Selling & General & Admin | 220.79M | 198.03M | 164.94M | 141.84M | 112.07M | 98.19M |
Research & Development | 9.58M | 9.17M | 15.43M | 6.74M | 2.06M | 1.72M |
Other Expenses | n/a | 9.52M | 9.39M | 6.52M | -13.59M | 91.4M |
Operating Expenses | 230.36M | 216.72M | 189.76M | 155.1M | 100.54M | 191.31M |
Interest Expense | 19.69M | 18.74M | 13.83M | 9.1M | 1.4M | 10.5M |
Selling & Marketing Expenses | n/a | 8.7M | 7.49M | 11.64M | n/a | n/a |
Cost & Expenses | 334.78M | 300.69M | 251.32M | 213.95M | 144.08M | 209.61M |
Income Tax Expense | 677K | 664K | 176K | 95K | 42K | 77K |
Shares Outstanding (Basic) | 64.47M | 62.02M | 56.92M | 56.07M | 49.77M | 33.74M |
Shares Outstanding (Diluted) | 64.47M | 62.02M | 56.92M | 56.07M | 49.77M | 33.74M |
EPS (Basic) | -0.80 | -0.81 | -1.08 | -1.33 | -0.94 | -4.83 |
EPS (Diluted) | -0.80 | -0.81 | -1.08 | -1.33 | -0.94 | -4.83 |
EBITDA | -22.53M | -25M | -41.81M | -53.85M | -39.06M | -144.75M |
EBIT | -31.27M | -31.02M | -47.68M | -57.58M | -45.37M | -152.43M |
Depreciation & Amortization | 8.74M | 6.02M | 5.87M | 3.72M | 6.31M | 7.68M |
Add to Watchlist
Select watchlists to add or remove EOLS